Skip to content

Author

Amir Valizadeh

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Linarin Reverses Doxorubicin Resistance by Modulating PTEN and MDR1 Expression in MCF-7 Breast Cancer Cells

Linarin may represent a promising adjunct therapeutic agent for overcoming resistance to conventional chemotherapeutic drugs, mediated through PTEN upregulation, which appears to play a role in suppressing P-gp-associated resistance mechanisms.

Vahid Mahmoudzadeh, Mehran Molavand, Azita Asadi et al. · 0 citations
Review Open access Aug 2026

The Multifaceted Role of MAPK/ERK Signaling Pathways in Cancer Drug Resistance: An Update

Cancer is among the leading causes of global mortality. In addition to uncontrolled proliferation, cancer cells activate survival pathways that favor the expansion of malignant cell populations. A critical component of these survival mechanisms is drug resistance, which often prevents the achievement of optimal therape...

Mehran Molavand, Amir Valizadeh, M. Majidinia et al. · 0 citations
Open access Aug 2026

Targeting p53/p21 Signaling: Linarin as a Novel Modulator of 5-FU Sensitization in Colorectal Cancer

Linarin demonstrates the capacity to potentiate 5-FU cytotoxicity by reactivating the p53/p21 pathway in CRC models harboring functional p53 by reactivating the p53/p21 pathway in linarin's sensitizing action in p53-competent cells.

Amir Valizadeh, M. Rahmati-Yamchi, A. Alihemmati et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.